Skip to content
healthcare.dev

Irinotecan hydrochloide

NDC 70700-169, Irinotecan hydrochloide, injection, from Xiromed LLC.

Product NDC
70700-169
Status
Listed
Labeler
Xiromed LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212993
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70700-169 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
70700-169-22707000169221 VIAL, SINGLE-DOSE in 1 CARTON (70700-169-22) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b26e5d27-dba5-7538-9e7b-48b358998cbb
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70700-169

Use it

Look up 70700-169 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70700-169 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70700-169. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.